Viewing Study NCT01269528


Ignite Creation Date: 2025-12-26 @ 10:33 AM
Ignite Modification Date: 2026-03-05 @ 9:11 PM
Study NCT ID: NCT01269528
Status: COMPLETED
Last Update Posted: 2015-11-10
First Post: 2011-01-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Prospective Evaluation of the Efficacy of Palivizumab Administration in Children Born at 29-32 Weeks of Gestation
Sponsor: Rambam Health Care Campus
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bronchial Hyperreactivity View
None Infant, Premature View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Palivizumab View
None Airway Hyperreactivity View
None EBC View
None MCT View